The glutathione-S-transferase mu 1 (GSTM1) null genotype and increased neutrophil response to low-level ozone (0.06 ppm)

Journal of Allergy and Clinical Immunology

Volumn 131, Issue 2, 2013, Pages 610-612

  Alexis, Neil E ^a   Lay, John C ^a   Zhou, Haibo ^a   Kim, Chong S ^b   Hernandez, Michelle L ^a   Kehrl, Howard ^b   Hazucha, Milan J ^a   Devlin, Robert B ^b   Diaz Sanchez, David ^b   Peden, David B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD86 ANTIGEN; GLUTATHIONE TRANSFERASE M1; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 8; OZONE; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC AIRWAY INFLAMMATION; ASTHMA; CELLULAR IMMUNITY; EXON; GENE SEQUENCE; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INNATE IMMUNITY; LETTER; NEUTROPHIL; PRIORITY JOURNAL; RISK FACTOR; SPIROMETRY;

EID: 84873404794     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.07.005     Document Type: Article

References (9)

1. N.E. Alexis, H. Zhou, J.C. Lay, B. Harris, M.L. Hernandez, and T.S. Lu The glutathione-S-transferase Mu 1 null genotype modulates ozone-induced airway inflammation in human subjects J Allergy Clin Immunol 124 2009 1222 1228 e1225
2. N.E. Alexis, J.C. Lay, M. Hazucha, B. Harris, M.L. Hernandez, and P.A. Bromberg Low-level ozone exposure induces airways inflammation and modifies cell surface phenotypes in healthy humans Inhal Toxicol 22 2010 593 600
3. N.E. Alexis, J.C. Lay, A. Haczku, H. Gong, W. Linn, and M.J. Hazucha Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers Environ Health Perspect 116 2008 799 805
4. J.C. Lay, N.E. Alexis, S.R. Kleeberger, R.A. Roubey, B.D. Harris, and P.A. Bromberg Ozone enhances markers of innate immunity and antigen presentation on airway monocytes in healthy individuals J Allergy Clin Immunol 120 2007 719 722
5. A.L. Lazaar, L.E. Sweeney, A.J. MacDonald, N.E. Alexis, C. Chen, and R. Tal-Singer SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans Br J Clin Pharmacol 72 2011 282 293
6. O. Holz, S. Khalilieh, A. Ludwig-Sengpiel, H. Watz, P. Stryszak, and P. Soni SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects Eur Respir J 35 2010 564 570
7. C.S. Kim, N.E. Alexis, A.G. Rappold, H. Kehrl, M.J. Hazucha, and J.C. Lay Lung function and inflammatory responses in healthy young adults exposed to 0.06 ppm ozone for 6.6 hours Am J Respir Crit Care Med 183 2011 1215 1221
8. M.L. Hernandez, J.C. Lay, B. Harris, C.R. Esther Jr., W.J. Brickey, and P.A. Bromberg Atopic asthmatic subjects but not atopic subjects without asthma have enhanced inflammatory response to ozone J Allergy Clin Immunol 126 2010 537 544
9. S. Garantziotis, Z. Li, E.N. Potts, K. Kimata, L. Zhuo, and D.L. Morgan Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice J Biol Chem 284 2009 11309 11317